<DOC>
	<DOC>NCT01796925</DOC>
	<brief_summary>The objective of the study is to confirm the safety and efficacy in patients utilizing the aura6000 System for the treatment of Obstructive Sleep Apnea (OSA).</brief_summary>
	<brief_title>Targeted Hypoglossal Neurostimulation Study #2</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<mesh_term>Signs and Symptoms</mesh_term>
	<mesh_term>Respiration Disorders</mesh_term>
	<mesh_term>Signs and Symptoms, Respiratory</mesh_term>
	<criteria>AHI &gt;20 Noncompliant to CPAP Willing to provide informed consent Willing to comply with all followup visits and evaluations BMI limits COPD Central Sleep Apnea Anatomic variations interfering with device placement or stability.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Apnea</keyword>
	<keyword>Respiration Disorders</keyword>
	<keyword>Signs and Symptoms</keyword>
	<keyword>Signs and Symptoms, Respiratory</keyword>
	<keyword>Sleep Apnea Syndromes</keyword>
	<keyword>Sleep Apnea, Obstructive</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Sleep Disorders, Intrinsic</keyword>
	<keyword>Sleep Disorders</keyword>
	<keyword>Nervous System Diseases</keyword>
</DOC>